![Kimberly Manhard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberly Manhard
Corporate Officer/Principal chez
CONNECT BIOPHARMA HOLDINGS LIMITED
Fortune : 1 M $ au 31/05/2026
Profil
Kimberly J.
Manhard is currently Director at Shoreline Biosciences, Inc. since 2021, Director at Toragen, Inc. since 2020, Independent Director at Inhibrx Biosciences, Inc. since 2024, Chief Development Officer & Executive VP at Connect Biopharma Holdings Ltd. since 2024, and Trustee at Reuben H.
Fleet Science Center.
Former roles include Director & Corporate Compliance Officer at Ardea Biosciences, Inc. from 2009 to 2016, Independent Director at Sanofi AATD, Inc. from 2020 to 2024, Executive Vice President-Drug Development at Heron Therapeutics, Inc. in 2023, Head-Regulatory Affairs at Bristol Myers Squibb Co., Principal at Eli Lilly & Co., Vice President-Regulatory Affairs at Exelixis, Inc. from 2002 to 2003, Head-Regulatory Affairs at Agouron Global Commercial Operations, Principal at G.H.
Besselaar Associates, and Senior VP-Global Strategic Planning & Execution at ACADIA Pharmaceuticals, Inc. in 2024.
Education includes undergraduate studies at the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,07 % | 03/06/2026 | 10 000 ( 0,07 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Kimberly Manhard
| Sociétés | Poste | Début |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 01/09/2024 |
Fleet Science Center
 Fleet Science Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit science center that connects people of all ages to the power of science to create a better future | Directeur/Membre du Conseil | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 19/05/2021 |
Toragen, Inc.
 Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Directeur/Membre du Conseil | 01/05/2020 |
Anciens postes connus de Kimberly Manhard
| Sociétés | Poste | Fin |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/09/2024 |
| INHIBRX, INC. | Directeur/Membre du Conseil | 30/05/2024 |
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/02/2023 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Directeur des opérations | 23/06/2009 |
| EXELIXIS, INC. | Conseiller Juridique Général | 01/01/2003 |
Formation de Kimberly Manhard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Agouron Global Commercial Operations | |
G.H. Besselaar Associates | |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Fleet Science Center
Fleet Science Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit science center that connects people of all ages to the power of science to create a better future | Commercial Services |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Health Technology |
